US 8936781
Macrocyclic compounds as hepatitis C virus inhibitors
granted A61KA61K38/21A61K45/06
Quick answer
US patent 8936781 (Macrocyclic compounds as hepatitis C virus inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K38/21, A61K45/06, A61P, A61P31/04